Benchmark Maintains Buy on OmniAb, Lowers Price Target to $6
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Robert Wasserman maintains OmniAb (NASDAQ:OABI) with a Buy and lowers the price target from $8 to $6.
Benchmark analyst Robert Wasserman maintains OmniAb (NASDAQ:OABI) with a Buy and lowers the price target from $8 to $6.